DK156722C - Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater - Google Patents

Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater

Info

Publication number
DK156722C
DK156722C DK154382A DK154382A DK156722C DK 156722 C DK156722 C DK 156722C DK 154382 A DK154382 A DK 154382A DK 154382 A DK154382 A DK 154382A DK 156722 C DK156722 C DK 156722C
Authority
DK
Denmark
Prior art keywords
preparing
analogy procedure
piperazinopyrimidine
derivatives
piperazinopyrimidine derivatives
Prior art date
Application number
DK154382A
Other languages
English (en)
Other versions
DK156722B (da
DK154382A (da
Inventor
Francois Audiau
Claude Gueremy
Gerard Le Fur
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Publication of DK154382A publication Critical patent/DK154382A/da
Publication of DK156722B publication Critical patent/DK156722B/da
Application granted granted Critical
Publication of DK156722C publication Critical patent/DK156722C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK154382A 1981-04-07 1982-04-05 Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater DK156722C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8106924 1981-04-07
FR8106924A FR2503162A1 (fr) 1981-04-07 1981-04-07 Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments

Publications (3)

Publication Number Publication Date
DK154382A DK154382A (da) 1982-10-08
DK156722B DK156722B (da) 1989-09-25
DK156722C true DK156722C (da) 1990-02-19

Family

ID=9257094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK154382A DK156722C (da) 1981-04-07 1982-04-05 Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater

Country Status (21)

Country Link
US (1) US4535080A (da)
EP (1) EP0063509B1 (da)
JP (1) JPS57179167A (da)
AR (1) AR231442A1 (da)
AT (1) AT386199B (da)
AU (1) AU549748B2 (da)
CA (1) CA1175427A (da)
DE (1) DE3262374D1 (da)
DK (1) DK156722C (da)
ES (4) ES511224A0 (da)
FI (1) FI78909C (da)
FR (1) FR2503162A1 (da)
GR (1) GR77331B (da)
HU (1) HU187673B (da)
IE (1) IE52872B1 (da)
IL (1) IL65422A (da)
MA (1) MA19438A1 (da)
MX (1) MX156087A (da)
NO (1) NO158739C (da)
PT (1) PT74712B (da)
ZA (1) ZA822344B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305524A1 (de) * 1983-02-18 1984-08-23 Celamerck Gmbh & Co Kg, 6507 Ingelheim Neue pyrimidinderivate
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPS6143173A (ja) * 1984-08-06 1986-03-01 Mitsui Petrochem Ind Ltd 新規ピリミジン誘導体およびその製法
EP0257102B1 (en) * 1986-02-24 1997-11-19 Mitsui Petrochemical Industries, Ltd. Agents for treating neurophathy
JP2561689B2 (ja) * 1986-02-24 1996-12-11 三井石油化学工業株式会社 神経疾患用治療薬
WO1989000423A1 (en) 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
CN101437843B (zh) * 2006-01-23 2013-08-07 密歇根州立大学评议会 抗草甘膦植物的育种方法及组合物
EP2326627A1 (en) * 2008-08-20 2011-06-01 Schering Corporation Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
PL2432767T3 (pl) * 2009-05-19 2013-11-29 Dow Agrosciences Llc Związki i sposoby zwalczania grzybów
CN103204816B (zh) * 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 哌嗪基嘧啶类衍生物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE485737A (da) * 1947-11-12
FR2257294B1 (da) * 1973-07-06 1977-07-01 Ugine Kuhlmann
NL129219C (da) * 1965-12-16
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
FR2173746B1 (da) * 1972-03-01 1975-04-25 Ugine Kuhlmann
FR2244520B1 (da) * 1973-07-06 1977-02-04 Ugine Kuhlmann
JPS578104B2 (da) * 1973-09-20 1982-02-15
GB1523274A (en) * 1974-08-05 1978-08-31 Ici Ltd Herbicidal compositions containing substituted pyrimidine
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
FR2311776A1 (fr) * 1975-05-23 1976-12-17 Sogeras Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides

Also Published As

Publication number Publication date
NO158739C (no) 1988-10-26
ES8400429A1 (es) 1983-10-16
FR2503162B1 (da) 1983-11-25
ES8400427A1 (es) 1983-10-16
EP0063509B1 (fr) 1985-02-20
DE3262374D1 (en) 1985-03-28
AT386199B (de) 1988-07-11
EP0063509A1 (fr) 1982-10-27
FI821203L (fi) 1982-10-08
ES8400428A1 (es) 1983-10-16
FR2503162A1 (fr) 1982-10-08
NO158739B (no) 1988-07-18
ES518975A0 (es) 1983-10-16
HU187673B (en) 1986-02-28
PT74712B (fr) 1983-10-25
FI78909B (fi) 1989-06-30
AU8245082A (en) 1982-10-14
ES8306745A1 (es) 1983-06-01
ATA127682A (de) 1987-12-15
AR231442A1 (es) 1984-11-30
IE820774L (en) 1982-10-07
ES518976A0 (es) 1983-10-16
DK156722B (da) 1989-09-25
IE52872B1 (en) 1988-03-30
AU549748B2 (en) 1986-02-13
MX156087A (es) 1988-07-04
ES511224A0 (es) 1983-06-01
DK154382A (da) 1982-10-08
ES518974A0 (es) 1983-10-16
JPS57179167A (en) 1982-11-04
IL65422A0 (en) 1982-07-30
NO821159L (no) 1982-10-08
ZA822344B (en) 1983-02-23
US4535080A (en) 1985-08-13
MA19438A1 (fr) 1982-12-31
PT74712A (fr) 1982-05-01
FI78909C (fi) 1989-10-10
FI821203A0 (fi) 1982-04-06
IL65422A (en) 1985-04-30
GR77331B (da) 1984-09-11
CA1175427A (fr) 1984-10-02

Similar Documents

Publication Publication Date Title
DK164593C (da) Analogifremgangsmaade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
DK157019C (da) Analogifremgangsmaade til fremstilling af 2-amino-4-hydroxyquinazolinderivater
DK491682A (da) Fremgangsmaade til fremstilling af substituerede benzimidazoler
DK159442C (da) Analogifremgangsmaade til fremstilling af 6,7-substitueret-4-ethyl-quinazoliner
DK161325C (da) Analogifremgangsmaade til fremstilling af imidazooe4,5-caa-pyridinderivater
DK150070C (da) Analogifremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater
DK358782A (da) Fremgangsmaade til fremstilling af pyridazinderivater
DK152132C (da) Analogifremgangsmaade til fremstilling af derivater af 5,6,7,7a-tetrahydro-4h-thienooe3,2-caapyridin-2-on
DK312082A (da) Fremgangsmaade til fremstilling af benzothiazolsulfonamidderivater
DK349682A (da) Fremgangsmaade til fremstilling af imidazoquinazolinderivater
DK156722C (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
DK164403C (da) Analogifremgangsmaade til fremstilling af benzothiazolinderivater
DK153583A (da) Fremgangsmaade til fremstilling af substituerede penemderivater
DK161310C (da) Analogifremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK501781A (da) Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater
DK163000C (da) Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK152674C (da) Analogifremgangsmaade til fremstilling af 3-metyltiometyl-4-oxo-quinolonderivater
DK4982A (da) Fremgangsmaade til fremstilling af pyridinylsubstituerede benzimidazolderivater
DK156219C (da) Analogifremgangsmaade til fremstilling af spirothiazolidinylpiperazinderivater
DK71783D0 (da) Fremgangsmade til fremstilling af pyrimidonderivater
DK371981A (da) Fremgangsmaade til fremstilling af aminoacetonitrilderivater
DK231581A (da) Fremgangsmaade til fremstilling af phenoxyaminopropanolderivater
DK253882A (da) Fremgangsmaade til fremstilling af 4-aminobenzylaminderivater

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed